Company Overview

Update
Founders:
Lenard M. Lichtenberger, Ronald R. Zimmerman
Headquarters:
Houston, TX
Funding:
$25.3M
Categories:
Biotechnology
Description:
PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.

Detailed Description

Update

PLx Pharma Inc., a pharmaceutical company, develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing a molecular complex of ibuprofen and phosphatidylcholine. It also provides other NSAID-PC products, which include PL4500 Indomethacin IV, a molecular complex of indomethacin and phosphatidylcholine that is developed in oral formulations and as an IV formulation for the treatment of PDA; and PL5100 Diclofenac, a molecular complex of diclofenac and phosphatidylcholine that is developed as an oral anti-inflammatory and analgesic drug. The company is based in Houston, Texas.

Current Team (6)

Update

Funding Rounds (5) - $25.3M

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    8285 El Rio

    Suite 130

    Houston, TX 77054

    USA

News (5)

Update